In addition, based on multinomial logistic regression, increased CTRP13 was associated with reduce the risk of T2DM, NAFLD and NAFLD + T2DM (Table 4). The gene discussed is C1QL3; the disease is metabolic dysfunction-associated steatotic liver disease.